Home › Therapeutic areas › Respiratory › Asthma

Asthma (8 companies)

Companies with an active program in Asthma.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ACRS Aclaris Therapeutics DermatologyGI/Hepatology+1 Rare 1 Phase 2 $536M 7
APGE Apogee Therapeutics DermatologyGI/Hepatology+1 Rare 3 Phase 2 — 9
CLDX Celldex Therapeutics DermatologyImmunology+1 1 Phase 3 $2.20B 6
CNTB Connect Biopharma Respiratory 2 Phase 2 $37.3M 4
CRVS Corvus Pharmaceuticals DermatologyOncology+1 Rare 1 Phase 3 $858M 7
INSM Insmed CardiovascularImmunology+3 Rare 1 Approved $26.7B 15
KYMR Kymera Therapeutics DermatologyImmunology+1 Rare 1 Phase 2 $10.4B 5
UPB Upstream Bio Respiratory 1 Phase 2 $115M 3